These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15119830)

  • 1. Chemokines and atherosclerosis.
    Sheikine Y; Hansson GK
    Ann Med; 2004; 36(2):98-118. PubMed ID: 15119830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
    Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
    Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines: inflammatory mediators of atherosclerosis.
    Liehn EA; Zernecke A; Postea O; Weber C
    Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-chemokine therapy for inflammatory diseases.
    Castellani ML; Bhattacharya K; Tagen M; Kempuraj D; Perrella A; De Lutiis M; Boucher W; Conti P; Theoharides TC; Cerulli G; Salini V; Neri G
    Int J Immunopathol Pharmacol; 2007; 20(3):447-53. PubMed ID: 17880758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
    Liu C; Cui G; Zhu M; Kang X; Guo H
    Int J Clin Exp Pathol; 2014; 7(12):8342-55. PubMed ID: 25674199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation.
    García-Ramallo E; Marques T; Prats N; Beleta J; Kunkel SL; Godessart N
    J Immunol; 2002 Dec; 169(11):6467-73. PubMed ID: 12444156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
    Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
    J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
    Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
    J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines and atherosclerosis.
    Terkeltaub R; Boisvert WA; Curtiss LK
    Curr Opin Lipidol; 1998 Oct; 9(5):397-405. PubMed ID: 9812193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death.
    Tarzami ST; Cheng R; Miao W; Kitsis RN; Berman JW
    J Mol Cell Cardiol; 2002 Feb; 34(2):209-21. PubMed ID: 11851360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A burgeoning family of biological mediators: chemokines and chemokine receptors.
    Le Y; Gong W; Shen W; Li B; Dunlop NM; Wang JM
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):143-50. PubMed ID: 10912618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase.
    Stroo I; Stokman G; Teske GJ; Raven A; Butter LM; Florquin S; Leemans JC
    Int Immunol; 2010 Jun; 22(6):433-42. PubMed ID: 20410256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
    Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
    J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for chemokine antagonists as therapeutics.
    Proudfoot AE; Power CA; Rommel C; Wells TN
    Semin Immunol; 2003 Feb; 15(1):57-65. PubMed ID: 12495641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokines and chemokine receptors in rheumatoid arthritis.
    Szekanecz Z; Kim J; Koch AE
    Semin Immunol; 2003 Feb; 15(1):15-21. PubMed ID: 12495637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines and angiogenesis.
    Szekanecz Z; Koch AE
    Curr Opin Rheumatol; 2001 May; 13(3):202-8. PubMed ID: 11333349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.